Literature DB >> 17376577

Lesions of the nucleus accumbens shell can reduce activity in the elevated plus-maze.

R R Horsley1, C Norman, H J Cassaday.   

Abstract

Across different behavioural tasks, nucleus accumbens (n.acc) lesions have generated conflicting effects on locomotor activity and in particular, the relative roles of the n.acc shell and core subfields in this have been controversial. To date there is only one study examining effects of lesions to the medial n.acc on elevated plus-maze (EPM) behaviour; these lesions were shown to increase both locomotor and exploratory activity. Given the well-documented distinction between shell and core, the present study sought to extend previous research by testing lesions selective to each n.acc subfield in the EPM. Results showed no statistical differences between core lesioned and sham-operated animals on any measure. In contrast, shell lesions consistently reduced locomotion and exploratory activity. This direction of effects is opposite to that previously observed after medial n.acc. lesions. In conclusion, locomotion and exploratory activity were clearly reduced by shell but not core lesions, consistent with other evidence for the functional heterogeneity of n.acc shell and core.

Mesh:

Year:  2007        PMID: 17376577     DOI: 10.1016/j.pnpbp.2007.02.007

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Effects of ethanol exposure and withdrawal on dendritic morphology and spine density in the nucleus accumbens core and shell.

Authors:  Veronica L Peterson; Brian A McCool; Derek A Hamilton
Journal:  Brain Res       Date:  2014-10-27       Impact factor: 3.252

2.  Deep brain stimulation affects conditioned and unconditioned anxiety in different brain areas.

Authors:  A van Dijk; M Klanker; N van Oorschot; R Post; R Hamelink; M G P Feenstra; D Denys
Journal:  Transl Psychiatry       Date:  2013-07-30       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.